Clobetasol propionate and Epipen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clobetasol propionate and Epipen. Common interactions include conjunctivitis among females and anger among males.

The phase IV clinical study analyzes what interactions people who take Clobetasol propionate and Epipen have. It is created by eHealthMe based on reports of 54 people who take Clobetasol propionate and Epipen from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 06, 2022

54 people who take Clobetasol propionate and Epipen together, and have interactions are studied.


What is Clobetasol propionate?

Clobetasol propionate has active ingredients of clobetasol propionate. It is often used in psoriasis. eHealthMe is studying from 8,109 Clobetasol propionate users for its effectiveness, alternative drugs and more.

What is Epipen?

Epipen has active ingredients of epinephrine. It is often used in anaphylaxis. eHealthMe is studying from 20,459 Epipen users for its effectiveness, alternative drugs and more.

Number of Clobetasol propionate and Epipen reports submitted per year:

Clobetasol propionate and Epipen drug interactions.

Common Clobetasol Propionate and Epipen drug interactions by gender *:

female:

  1. Conjunctivitis
  2. Death
  3. Decreased appetite
  4. Drug hypersensitivity
  5. Dyspepsia
  6. Eczema
  7. Emotional disorder
  8. Emotional distress
  9. Eye irritation
  10. Eye pain

male:

  1. Anger
  2. Cd4 lymphocytes decreased
  3. Anxiety
  4. Asthma
  5. Breath odour
  6. Burning sensation
  7. Cough
  8. Dermatitis atopic
  9. Diaphragmatic disorder
  10. Dry eye

Common Clobetasol Propionate and Epipen drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Dry eye
  2. Eye irritation
  3. Ocular hyperaemia

20-29:

  1. Lymphocyte count increased
  2. Nasal congestion
  3. Oropharyngeal pain
  4. Pain
  5. Pyrexia
  6. Upper respiratory tract infection
  7. Urticaria
  8. Nausea
  9. Chest discomfort
  10. Cold sweat

30-39:

  1. Malaise
  2. Pain
  3. Pain in extremity
  4. Sleep disorder
  5. Tremor
  6. Amnesia
  7. Arthritis
  8. Flushing
  9. Influenza
  10. Movement disorder

40-49:

  1. Asthenia
  2. Dizziness
  3. Drug ineffective
  4. Fall
  5. Foot fracture
  6. Hemianopia
  7. Hyperreflexia
  8. Hypoaesthesia
  9. Ligament rupture
  10. Multiple sclerosis relapse

50-59:

  1. Bronchitis
  2. Contusion
  3. Dry eye
  4. Fall
  5. Foreign body sensation in eyes
  6. Iridocyclitis
  7. Multiple allergies
  8. Pyrexia
  9. Skin injury
  10. Urticaria

60+:

  1. Fatigue
  2. Weight increased
  3. Cellulitis
  4. Conjunctival oedema
  5. Contusion
  6. Cough
  7. Decreased appetite
  8. Drug ineffective
  9. Dry eye
  10. Dry skin

Common conditions people have *:

  1. Asthma: 13 people, 24.07%
  2. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 9 people, 16.67%
  3. Hypersensitivity: 9 people, 16.67%
  4. Immunodeficiency Common Variable: 8 people, 14.81%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 12.96%
  6. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 6 people, 11.11%
  7. High Blood Pressure: 6 people, 11.11%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 9.26%
  9. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 9.26%
  10. Infection: 4 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Clobetasol propionate and Epipen?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Clobetasol propionate and Epipen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Clobetasol propionate side effects:

Browse all side effects of Clobetasol propionate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Epipen side effects:

Browse all side effects of Epipen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Clobetasol propionate interactions:

Browse all interactions between Clobetasol propionate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Epipen interactions:

Browse all interactions between Epipen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clobetasol propionate and epinephrine (the active ingredients of Clobetasol propionate and Epipen, respectively), and Clobetasol propionate and Epipen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Clobetasol propionate and Epipen.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: